Stock Events

Stock Events

Calithera Biosciences 

$0.000100
11
-$0.00-75% Wednesday 18:22

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.001
52W Low
0.0001
Volume
315
Avg. Volume
457
Mkt Cap
487.2
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

22NovExpected
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2024
Q2 2024
Q3 2024
-3.7
-3
-2.29
-1.59
Expected EPS
-3.027673
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
0Revenue
-21.29MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CALA. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Incyte
INCY
Mkt Cap22.73B
Incyte Corporation focuses on the discovery, development, and commercialization of various therapeutics, including cancer treatments that directly compete with Calithera's oncology portfolio.
Exelixis
EXEL
Mkt Cap13.77B
Exelixis, Inc. is involved in the development and commercialization of cancer treatments, competing in the oncology space with drugs that may target similar pathways as Calithera's products.
Array Technologies
ARRY
Mkt Cap1.1B
Array BioPharma Inc. specializes in the development of drugs for the treatment of cancer, including targeted small molecule drugs designed to treat patients with specific mutations, competing with Calithera's approach to cancer therapy.
Agios Pharmaceuticals
AGIO
Mkt Cap2.25B
Agios Pharmaceuticals, Inc. focuses on cellular metabolism and rare genetic diseases, including cancer metabolism, which competes with Calithera's research into cancer cell metabolism.
Novartis
NVS
Mkt Cap296.54B
Novartis AG, through its extensive portfolio of oncology drugs, competes across a broad range of cancer types, potentially including those targeted by Calithera's treatments.
Puma Biotechnology
PBYI
Mkt Cap412.79M
Puma Biotechnology, Inc. focuses on the development and commercialization of a targeted therapy for breast cancer, competing in the oncology market where Calithera is also seeking to establish a presence.

About

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Show more...
CEO
Ms. Stephanie Wong CPA
Employees
8
Country
United States
ISIN
US13089P5070

Listings

OTC Link
US
CALA

0 Comments

Share your thoughts

FAQ

What is Calithera Biosciences stock price today?▼
The current price of CALA is $0.00 USD — it has decreased by -75% in the past 24 hours. Watch Calithera Biosciences stock price performance more closely on the chart.
What is Calithera Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Calithera Biosciences stocks are traded under the ticker CALA.
Is Calithera Biosciences stock price growing?▼
CALA stock has fallen by -75% compared to the previous week, the month change is a -66.67% fall, over the last year Calithera Biosciences has showed a +0% increase.
What is Calithera Biosciences market cap?▼
Today Calithera Biosciences has the market capitalization of 487.2
What is Calithera Biosciences revenue for the last year?▼
Calithera Biosciences revenue for the last year amounts to 0 USD.
What is Calithera Biosciences net income for the last year?▼
CALA net income for the last year is -21.29M USD.
How many employees does Calithera Biosciences have?▼
As of July 02, 2026, the company has 8 employees.
In which sector is Calithera Biosciences located?▼
Calithera Biosciences operates in the Health & Wellness sector.
When did Calithera Biosciences complete a stock split?▼
The last stock split for Calithera Biosciences was on June 15, 2022 with a ratio of 1:20.
Where is Calithera Biosciences headquartered?▼
Calithera Biosciences is headquartered in South San Francisco, United States.